A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis.

Project: Research

Project Details

StatusActive
Effective start/end date28/08/1931/12/21

Keywords

  • Gastroenterology
  • Ulcerative colitis
  • Clinical trial